• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

J&J to Stop Selling Skin Lightening Products

Author(s):

This week, consumer magazines highlight cellulite tips and tricks, skin cancer in POC and more.

patient insight June 29

In this week’s Patient Insight, Elle discusses Johnson & Johnson’s decision to stop selling skin lightening creams overseas, Cosmopolitan details keratosis pilaris treatments and tips to get rid of cellulite, and InStyle talks controversial oxybenzone in sunscreen and skin cancer in people of color.

Skin

Johnson & Johnson Will Finally Stop Selling Skin Lightening Products Overseas

Chicken Skin: 9 Best Keratosis Pilaris Treatments for My Bumpy Arms and Skin

Only 25% of Sunscreens Do Not Contain Controversial Ingredients, According to One Study

Body

How to Get Rid of Cellulite: 8 Tips, Tricks, and Products From Dermatologists

Melanoma

Yes, Black People Can Get Skin Cancer — It Happened to Me at 22

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.